1. Teprenon use within 2 weeks of study treatment2. Patient who needs ventilator or ECMO3. Active infectious disease requiring systemic treatment except for stable NTM4. During pregnancy, within 28 days of postparturition, or during lactation.5. Unidentified patient

1. Teprenon use within 2 weeks of study treatment2. Patient who needs ventilator or ECMO3. Active infectious disease requiring systemic treatment except for stable NTM4. During pregnancy, within 28 days of postparturition, or during lactation.5. Unidentified patient